Dr. Luqman Seidu
Dr. Seidu served as faculty in the Department of Allergy/Immunology at Cincinnati Children’s Hospital Medical Center and the Cincinnati Center for Eosinophilic Disorders (CCED) prior to starting his own practice in Atlanta at Omni Allergy, Immunology and Asthma. His responsibilities included instruction of residents and fellows at the institution as well diagnosing and managing both adult and pediatric patients with eosinophilic disorders, food allergies, asthma, eczema, immune dysregulation and other disorders. Immediately prior, he completed a three year allergy/immunology fellowship at the co-joint program at the Cincinnati Children’s Medical Center and the University of Cincinnati Medical Center. He started his fellowship with laboratory research training and was the first fellow at Cincinnati Children’s to be trained under the T32 grant by the National Institute of Allergy and Infectious Diseases (NIAID).
Dr. Seidu had his fellowship structured to include basic science laboratory research and training during all three years of his training; focused on molecular biology research his first year with concurrent clinical responsibilities. His second and third years were structured to include protected time for continued bench molecular and clinical science research while expanding his clinical patient responsibilities. During his fellowship, he also spent two years attending the immunodeficiency clinics in the Cincinnati Children’s Medical Center as well as training in the University of Cincinnati and Bernstein Allergy clinics. His basic science research mentors were Marc Rothenberg, M.D., Ph.D. and Simon Hogan, Ph.D. Immediately prior to his fellowship, he completed residency at a Rainbow Babies Hospital affiliate program and graduated from an accelerated, combined BS/MD program in northeast Ohio.
He has been first author or co-author on several basic/molecular science and clinical publications in peer-reviewed journals on immune regulation in the intestine, allergic intestinal disease, eosinophilic diseases, inflammatory bowel disease, drug allergy, immunology and clinical allergy. Dr. Seidu has participated as a primary investigator or co-investigator on several clinical research studies dealing with immunodeficiency, immunoglobulin replacement, anti-IL-5 and monoclonal antibodies in the treatment of eosinophilic esophagitis and other eosinophilic disorders. He has spoken many times across the country about eosinophilic gastrointestinal disorders and food allergy. He has served as reviewer for numerous journal articles related to allergy/immunology as well as gastroenterology during fellowship and continues to participate as an editor/reviewer for resources such as WebMD/Medscape.
He is affiliated with Children’s Healthcare of Atlanta, Cincinnati Children’s Medical Center, and with Morehouse School of Medicine where he serves as an adjunct professor in Department of Pediatrics. Additionally, he is the director of allergy for the SEED (SouthEast Eosinophilic Disease) Center of Atlanta. He is a member of the American Academy of Allergy and Immunology, the American College of Allergy and Immunology, and the American Academy of Pediatrics.
Contact
Dr. Luqman Seidu
Georgia Asthma, Immunology and Allergy
5445 Meridian Mark Road, Suite 390, Atlanta, GA 30342
(404) 257-3338
http://omniallergy.com/physicians.htm
OIT Details
State: Georgia
Treats single/multi allergens at once: Single
Offers SLIT for food allergens: No
Additional Features:
Articles in Our Research & Learn Center
Map to Office(s)
[property_map1]
[property_map2]
[property_map3]
[property_map4]
[property_map5]
Clinical Trials
- Immunoglobulin, Diagnosis, Evaluation, and Key Learnings Patient Registry (IDEaL™) Start of enrollment: 2010 Aug 01
Seidu, L.,Kearns, S.
Publications & Presentations
PubMed
- Successful administration of cytarabine in a 16-month-old girl with acute myelogenous leukemia and cytarabine syndrome. Metz, K. A., Johnson, T., Hershey, G. K., Lierl, M. B., Seidu, L., Burns, K., Assa’ad, A.; Ann Allergy Asthma Immunol. 2009 Feb 01.
- Resistin-like molecule alpha decreases glucose tolerance during intestinal inflammation. Munitz, A., Seidu, L., Cole, E. T., Ahrens, R., Hogan, S. P., Rothenberg, M. E.; J Immunol. 2009 Feb 15.
- Resistin-like molecule alpha enhances myeloid cell activation and promotes colitis. Munitz, A., Waddell, A., Seidu, L., Cole, E. T., Ahrens, R., Hogan, S. P., Rothenberg, M. E.; J Allergy Clin Immunol. 2008 Dec 01.
- Chronic vulvovaginal Candida hypersensitivity: An underrecognized and undertreated disorder by allergists. Bernstein JA, Seidu L. Allergy Rhinol (Providence). 2015 Jan;6(1):44-9. doi: 10.2500/ar.2015.6.0113.
- Intestinal macrophage/epithelial cell-derived CCL11/eotaxin-1 mediates eosinophil recruitment and function in pediatric ulcerative colitis.
Ahrens R, Waddell A, Seidu L, Blanchard C, Carey R, Forbes E, Lampinen M, Wilson T, Cohen E, Stringer K, Ballard E, Munitz A, Xu H, Lee N, Lee JJ, Rothenberg ME, Denson L, Hogan SP. J Immunol. 2008 Nov 15;181(10):7390-9.
Forbes EE, Groschwitz K, Abonia JP, Brandt EB, Cohen E, Blanchard C, Ahrens R, Seidu L, McKenzie A, Strait R, Finkelman FD, Foster PS, Matthaei KI, Rothenberg ME, Hogan SP. J Exp Med. 2008 Apr 14;205(4):897-913. doi: 10.1084/jem.20071046. Epub 2008 Mar 31.
- Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. Hogan SP, Seidu L, Blanchard C, Groschwitz K, Mishra A, Karow ML, Ahrens R, Artis D, Murphy AJ, Valenzuela DM, Yancopoulos GD, Rothenberg ME. J Allergy Clin Immunol. 2006 Jul;118(1):257-68.
